Our goal is to build a new kind of biopharmaceutical company; one that challenges industry norms and believes that when patients benefit, everyone benefits.
Horizon Pharma plc is a biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs. We market 11 medicines through our rare disease, rheumatology and primary care business units.
Founded in 2008 as a small startup with only a handful of employees and no office space to call our own, Horizon has evolved into a global biopharmaceutical company with more than $1 billion in net sales and over 1,000 employees in less than a decade.